Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severely impacts quality of life, mental health, and work productivity.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

The exact cause of frontal fibrosing alopecia is unknown, but it's not likely due to sunscreen.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

People with alopecia areata may be more likely to have a certain type of hearing loss.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Early intervention and patient education are crucial for managing alopecia areata.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Insulin therapy helped a man with autoimmune issues regrow his hair.